Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis.

Federica VinciguerraCarla Di StefanoRoberto BarattaAlfredo PulvirentiGiuseppe MastrandreaLuigi PiazzaFabio GuccioneGiuseppe NavarraLucia Frittitta

Published in: Obesity surgery (2024)

Liraglutide 3 mg emerges as a viable option for significant weight loss in patients experiencing IWL or WR after BS. Its inclusion in a multimodal, sequential obesity treatment approach proves promising.

Keyphrases

weight loss
bariatric surgery
high dose
systematic review
end stage renal disease
ejection fraction
newly diagnosed
obese patients
metabolic syndrome
type diabetes
chronic kidney disease
gastric bypass
peritoneal dialysis
low dose
prognostic factors
stem cell transplantation
meta analyses
glycemic control